Michael John Goldacre (born 3 January 1944 in Melbourne, Australia) is an Australian-born British medical doctor and academic. He has been a fellow of Magdalen College since 1985 and was awarded a Title of Distinction as Professor of Public Health at the University of Oxford in 2002. [1] He is a Fellow of the Royal College of Physicians,a Fellow of the Faculty of Public Health, and a Fellow of the Royal Society of Medicine [1]
Michael Goldacre was born on 3 January 1944 in Melbourne, Australia. [1] His great-great-grandfather was journalist and politician Sir Henry Parkes, father of the Australian Federation.[ citation needed ] He was educated at Bec School, a grammar school in London, England. He studied medicine at Magdalen College, Oxford, graduating with a Bachelor of Arts (BA) degree, with first class honours, and at University College Hospital, London, graduating with Bachelor of Medicine, Bachelor of Surgery (BM BCh) degrees. [1]
He has been at the University of Oxford since 1974, when he was appointed clinical lecturer in social and community medicine. [1] He was the Director of the Unit of Health-Care Epidemiology and the Oxford Record Linkage Study from 1986 to 2015. He was also scientific director of the South East England Public Health Observatory from 2000 until 2005, and director of the UK Medical Careers Research Group from 1993 to 2015. [1]
In 1973 he married Australian singer Susan M Traynor, who performed in the band Fox and as Noosha Fox, in Wandsworth, London. [2] One of their sons is the science writer Ben Goldacre. [3]
Magdalen College is a constituent college of the University of Oxford. It was founded in 1458 by Bishop of Winchester William of Waynflete. It is one of the wealthiest Oxford colleges, as of 2022, and one of the strongest academically, setting the record for the highest Norrington Score in 2010 and topping the table twice since then. It is home to several of the university's distinguished chairs, including the Agnelli-Serena Professorship, the Sherardian Professorship, and the four Waynflete Professorships.
Ben Michael Goldacre is a British physician, academic and science writer. He is the first Bennett Professor of Evidence-Based Medicine and director of the Bennett Institute for Applied Data Science at the University of Oxford. He is a founder of the AllTrials campaign and OpenTrials, aiming to require open science practices in clinical trials.
Dame Frances Clare Kirwan, is a British mathematician, currently Savilian Professor of Geometry at the University of Oxford. Her fields of specialisation are algebraic and symplectic geometry.
Dame Bridget Margaret Ogilvie, is an Australian and British scientist.
Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.
Alastair Buchan is a British neurologist and researcher in stroke medicine. His main research interest is how to make neuroprotection a reality in the clinic. From October 2008 until January 2017, he served as the Dean of Medicine and the Head of the Medical Sciences Division, University of Oxford. He currently holds the Chair of Stroke Research at the University of Oxford.
Sir Edward Byrne is a neuroscientist who, as of September 2024, serves as President of King Abdullah University of Science and Technology (KAUST), located in Thuwal, Saudi Arabia. Byrne served as President and Principal of King's College London from August 2014 until January 2021. and was previously President Vice-Chancellor of Monash University.
John Andrew Todd is a British geneticist who is Professor of Precision Medicine at the University of Oxford, director of the Wellcome Center for Human Genetics and the JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, in addition to Jeffrey Cheah Fellow in Medicine at Brasenose College. He works in collaboration with David Clayton and Linda Wicker to examine the molecular basis of type 1 diabetes.
Professor Samuel Frank Berkovic is an Australian neurologist and Laureate Professor in the Department of Medicine, University of Melbourne and Director of the Epilepsy Research Centre at Austin Health.
Michael B. Bracken is an American perinatal epidemiologist. He is the Susan Dwight Bliss Professor of Epidemiology at the Yale School of Public Health, and Professor of Obstetrics, Gynecology and Reproductive Sciences, and Professor of Neurology at the Yale School of Medicine. He is co-director of the Yale Center for Perinatal, Pediatric and Environmental Epidemiology.
Benjamin Guy Davis is a British chemist who is Professor of Chemical biology in the Department of Pharmacology and a member of the Faculty in the Department of Chemistry at the University of Oxford and a Fellow of Pembroke College, Oxford. He holds the role of Science Director for Next Generation Chemistry (2019-2024) and Deputy Director (2020-) at the Rosalind Franklin Institute.
David John Hunter is an Australian epidemiologist and the Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health. He was previously a professor in the Department of Epidemiology and the Department of Nutritionof Harvard University. He was associate epidemiologist at the Channing Laboratory, Brigham and Women's Hospital, where he was involved with the programs in breast cancer, cancer epidemiology, and cancer genetics research teams.
Sir Adrian Vivian Sinton Hill, is a British-Irish vaccinologist who is Director of the Jenner Institute and Lakshmi Mittal and Family Professor of Vaccinology at the University of Oxford, an honorary Consultant Physician in Infectious Diseases, and Fellow of Magdalen College, Oxford. Hill is a leader in the field of malaria vaccine development and was a co-leader of the research team which produced the Oxford–AstraZeneca COVID-19 vaccine, along with Professor Sarah Gilbert of the Jenner Institute and Professor Andrew Pollard of the Oxford Vaccine Group.
Edith Yvonne Jones is a British molecular biologist who is director of the Cancer Research UK Receptor Structure Research Group at the University of Oxford and a Fellow of Jesus College, Oxford. She is widely known for her research on the molecular biology of cell surface receptors and signalling complexes.
Sir Andrew James McMichael, is an immunologist, Professor of Molecular Medicine, and previously Director of the Weatherall Institute of Molecular Medicine at the University of Oxford. He is particularly known for his work on T cell responses to viral infections such as influenza and HIV.
Sir Nicholas John White is a British medical doctor and researcher, specializing in tropical medicine in developing countries. He is known for his work on tropical diseases, especially malaria using artemisinin-based combination therapy.
Colin Baigent is a British academic physician and cardiovascular epidemiologist. He is a professor of epidemiology, Director of the Medical Research Council Population Health Research Unit at the University of Oxford, and deputy director of the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), part of Oxford Population Health. His work is focused in the design and coordination of large-scale randomised trials and the use of meta-analysis to assess the efficacy and safety of drugs for the prevention of cardiovascular disease (CVD) or premature death.
Ilina Singh is a Professor of Neuroscience & Society at the University of Oxford, England, United Kingdom. She is also a co-director at the Wellcome Trust Centre for Ethics and the Humanities, and a research fellow at the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre.
Sir Andrew John Pollard is the Ashall Professor of Infection & Immunity at the University of Oxford and a Fellow of St Cross College, Oxford. He is an Honorary Consultant Paediatrician at John Radcliffe Hospital and the Director of the Oxford Vaccine Group. He is the Chief Investigator on the University of Oxford COVID-19 Vaccine trials and has led research on vaccines for many life-threatening infectious diseases including typhoid fever, Neisseria meningitidis, Haemophilus influenzae type b, streptococcus pneumoniae, pertussis, influenza, rabies, and Ebola.
Kevin Marsh is a British Malariologist, academic and a researcher. He is a professor of Tropical Medicine and Director of Africa Oxford Initiative at University of Oxford. He is also a senior advisor at African Academy of Sciences.